Matches in Nanopublications for { ?s ?p "[Therefore, in patients with CLL/SLL and rapidly enlarging asymmetric lymphadenopathy and/or extranodal tumors, we strongly advise FCM of fine-needle aspiration biopsy (FNAB) material, including CD62L, CD52, and CD71 analysis as well as assessment of karyotype and at least MYC abnormalities by FISH of the same FNAB material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_assertion description "[Therefore, in patients with CLL/SLL and rapidly enlarging asymmetric lymphadenopathy and/or extranodal tumors, we strongly advise FCM of fine-needle aspiration biopsy (FNAB) material, including CD62L, CD52, and CD71 analysis as well as assessment of karyotype and at least MYC abnormalities by FISH of the same FNAB material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248306.RAK_uU_pw82xRvmqwVB7wgfUl2QR6Oj6m_dz9sGqyiJW4130_provenance.
- NP730515.RA_7wuVcgZzMJWAZ3nRCPd7pBRgXgbC_5kbkBPGAirawI130_assertion description "[Therefore, in patients with CLL/SLL and rapidly enlarging asymmetric lymphadenopathy and/or extranodal tumors, we strongly advise FCM of fine-needle aspiration biopsy (FNAB) material, including CD62L, CD52, and CD71 analysis as well as assessment of karyotype and at least MYC abnormalities by FISH of the same FNAB material.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730515.RA_7wuVcgZzMJWAZ3nRCPd7pBRgXgbC_5kbkBPGAirawI130_provenance.